The concept of war-related “therapeutic geographies” emerged a decade ago on the heels of the Arab Spring, during a period when the US had (temporarily) pulled out of Iraq and another set of wars in Syria and Libya were newly underway. As a product of these overlapping wars, social scientists and physicians in the Middle East region were grappling with the fact that the destruction and transformation of hospitals compelled many patients and their families to embark upon circuitous, transnational trajectories of care-seeking across borders. “Therapeutic geographies” captured the emergence of new transnational networks and circuits of care related to the immediate and long-term impact of war. A decade after the formulation of the concept, these transnational therapeutic geographies have continued to define the experience of illness for countless individuals and families in the Middle East region. New iterations of war, particularly the series of local and international conflicts related to the Islamic State in Iraq and Syria (ISIS), in addition to the COVID-19 pandemic, have continued to reshape local and cross-border pathways of care, with profound implications for the experience of illness, the lines between public and private, and the practices around palliation and dying. The challenge of this paper is to develop an ethnographic account that links ongoing transformations in the geographies and spaces of care with the illness experience of individuals and those who care for them. Building on eight years of ethnographic research with Iraqi cancer patients navigating oncology within and across borders during war, this paper traces the lives, care-seeking journeys, and deaths of cancer patients from the start of the ISIS conflict to the present moment. As the story of cancer in Iraq is not only about the war-related transformation of oncology but also unresolved questions around the carcinogenic afterlives of war munitions and waste, the ethnography is attentive to the ways in which patients and their caregivers draw associations between the uncertain pathways of care and the uncertain etiological status of the disease.